Lower limb orthopaedic surgery results in changes to coagulation and non-specific inflammatory biomarkers, including selective clinical outcome measures

European Journal of Medical Research

Jim F Middleton⁴  Salah S Bastawrous⁵  David R Edwards¹  Beverly D Hendricks²  Stephen F Hughes³ 

[1] Haematology Department, BCUHB, Gwynedd Hospital, North Wales, UK;Haematology Department, BCUHB, Glan Clwyd Hospital, North Wales, UK;Leopold Muller Arthritis Research Centre, RJAH Orthopaedic Hospital, Medical School, Keele University, Keele, UK;Faculty of Medicine and Dentistry, School of Oral and Dental Science, University of Bristol, Bristol, UK;Orthopaedics Department, BCUHB, Glan Clwyd Hospital, North Wales, UK

关键词: Orthopaedic surgery;    Inflammation;    Coagulation;   

Others  :  817808
DOI  :  10.1186/2047-783X-18-40

 received in 2013-08-22, accepted in 2013-10-30,  发布年份 2013

【 摘 要 】

Background

With an aging society and raised expectations, joint replacement surgery is likely to increase significantly in the future. The development of postoperative complications following joint replacement surgery (for example, infection, systemic inflammatory response syndrome and deep vein thrombosis) is also likely to increase. Despite considerable progress in orthopaedic surgery, comparing a range of biological markers with the ultimate aim of monitoring or predicting postoperative complications has not yet been extensively researched. The aim of this clinical pilot study was to test the hypothesis that lower limb orthopaedic surgery results in changes to coagulation, non-specific markers of inflammation (primary objective) and selective clinical outcome measures (secondary objective).

Methods

Test subjects were scheduled for elective total hip replacement (THR) or total knee replacement (TKR) orthopaedic surgery due to osteoarthritis (n = 10). Platelet counts and D-dimer concentrations were measured to assess any changes to coagulation function. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were measured as markers of non-specific inflammation. Patients were monitored regularly to assess for any signs of postoperative complications, including blood transfusions, oedema (knee swelling), wound infection, pain and fever.

Results

THR and TKR orthopaedic surgery resulted in similar changes of coagulation and non-specific inflammatory biomarkers, suggestive of increased coagulation and inflammatory reactions postoperatively. Specifically, THR and TKR surgery resulted in an increase in platelet (P = 0.013, THR) and D-dimer (P = 0.009, TKR) concentrations. Evidence of increased inflammation was demonstrated by an increase in CRP and ESR (P ≤ 0.05, THR and TKR). Four patients received blood transfusions (two THR and two TKR patients), with maximal oedema, pain and aural temperatures peaking between days 1 and 3 postoperatively, for both THR and TKR surgery. None of the patients developed postoperative infections.

Conclusions

The most noticeable changes in biological markers occur during days 1 to 3 postoperatively for both THR and TKR surgery, and these may have an effect on such postoperative clinical outcomes as oedema, pyrexia and pain. This study may assist in understanding the postoperative course following lower limb orthopaedic surgery, and may help clinicians in planning postoperative management and patient care.

【 授权许可】

   
2013 Hughes et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]National Joint Registry (NJR): Public and Patient Guide to the NJR Annual Report 2012. [http://www.njrcentre.org.uk/NjrCentre/Portals/0/Documents/England/Reports/9th_annual_report/NJR%20Public%20and%20Patient%20Guide%202012%20Online.pdf webcite]
• [2]Frampton L: Prosthetic joints challenges posed by infection. Biomed Sci Gaz 2013, 57(4):213-215.
• [3]Høgevold HE, Lyberg T, Reikerås O: Changes in leukocyte subpopulations following total hip replacement surgery. Effects of high doses of corticosteroids. Scand J Clin Lab Inves 1999, 51(5):443-451.
• [4]Harr JN, Moore EE, Chin TL, Ghasabyan A, Gonzalez E, Wohlauer MV, Banerjee A, Silliman CC, Sauaia A: Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg 2013, 74(3):756-762.
• [5]Bates SM: D-dimer assays in diagnosis and management of thrombotic and bleeding disorders. Semin Thromb Hemost 2012, 38(7):673-682.
• [6]Niimi R, Hasegawa M, Sudo A, Shi D, Yamada T, Uchida A: Evaluation of soluble fibrin and D-dimer in the diagnosis of postoperative deep vein thrombosis. Biomarkers 2010, 15(2):149-157.
• [7]De Moerloose P: Performances of the Vidas D-dimer new assay for the exclusion of venous thromboembolism. Thromb Haemost 2001, 85:185-186.
• [8]Margheritini F, Camillieri G, Mancini L, Mariani PP: C-reactive protein and erythrocyte sedimentation rate changes following arthroscopically assisted anterior cruciate ligament reconstruction. J Knee Surg Sports Traumatol Arthrosc 2001, 6(9):343-345.
• [9]Sakić K, Sakić S: Treatment of acute loss of blood in major elective orthopedic surgery procedures. Lijec Vjesn 1995, 117(2):35-37.
• [10]Prasad N, Mullaji A, Padmanabhan V: Factors affecting in total knee arthoplasty. J Bone Joint Surg Br Proc 2006, 88-B:182.
• [11]Lee J, Singletary R, Schmader K, Anderson DJ, Bolognesi M, Kaye KS: Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am 2006, 88(8):1705-1712.
• [12]Pasero C, McCaffery M: Orthopaedic postoperative pain management. J Perianesth Nurs 2007, 3:160-174.
• [13]Sassoon A, D’Apuzzo M, Sems S, Cass J, Mabry T: Total hip arthroplasty for femoral neck fracture: comparing in-hospital mortality, complications, and disposition to an elective patient population. J Arthroplasty 2013, 28:1659-1662.
• [14]Price CP, Trull AK, Berry D, Gorman EG: Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein. J Immunol Meth 1987, 99:205-211.
• [15]Horsti J, Rontu R, Colling A: A comparison between the Starrsed auto-compact erythrocyte sedimentation rate instrument and the Westergren method. J Clin Med Res 2010, 2(6):261-265.
• [16]Muñoz M, García-Erce JA, Cuenca J, Solano VM: Course of D-dimer concentrations after total knee replacement surgery: effect of allogeneic and unwashed drainage blood transfusion. Trans Alternatives in Trans Med 2006, 8:135-141.
• [17]White J, Kelly M, Dunsmuir R: C-reactive protein level after total hip and total knee replacement. J Bone Joint Surg [Br] 1998, 80-B:909-911.
• [18]Orrego LM, Pérez CM, Pérez YM, Cheyre EJ, Mardones PR: Plasma C reactive protein in elective orthopedic surgery. Rev Med Chil 2005, 11:1341-1348.
• [19]Lowe GD: Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005, 3(8):1618-1627.
• [20]Hughes SF, Hendricks BD, Edwards DR, Middleton JF: Tourniquet-applied upper limb orthopaedic surgery results in increased inflammation and changes to leukocyte, coagulation and endothelial markers. PLoS ONE 2010, 5(7):e11846.
• [21]Holm B, Kristensen MT, Bencke J, Husted H, Kehlet H, Bandholm T: Loss of knee-extension strength is related to knee swelling after total knee arthroplasty. Arch Phy Med Rehabil 2010, 91(11):177-1776.
• [22]Hughes SF, Hendricks BD, Edwards DR, Bastawrous SS, Roberts GE, Middleton JF: Mild episodes of tourniquet-induced forearm ischaemia-reperfusion injury results in leukocyte activation and changes in inflammatory and coagulation markers. J Inflamm [Lond] 2007, 4(12):1-8.